Independent clonal origin of multiple uterine leiomyomas that was determined by X chromosome inactivation and microsatellite analysis.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  2005-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.AJOG.2005.02.097PMID 16202732
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microallelotyping defines novel regions of loss of heterozygosity in uterine leiomyomas

  2005cited by this paper
• Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: Genetic linkage analysis and FISH studies

  2004cited by this paper
• Mammalian X-chromosome inactivation.

  2003cited by this paper
• Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

  2002cited by this paper
• Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity

  2002cited by this paper
• Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas

  2002cited by this paper
• Multiple cutaneous and uterine leiomyomas: refinement of the genetic locus for multiple cutaneous and uterine leiomyomas on chromosome 1q42.3-43.

  2002cited by this paper
• Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies

  2002cited by this paper
• Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43.

  2001cited by this paper
• Genetics of uterine leiomyomata

  2000cited by this paper
• Genetics of uterine leiomyomata.

  2000cited by this paper
• The identification of monoclonality in human aberrant crypt foci.

  1999cited by this paper
• Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer.

  1999cited by this paper
• Rapid and accurate determination of (CAG)n repeats in the androgen receptor gene using polymerase chain reaction and automated fragment analysis.

  1999cited by this paper
• Allelotype of uterine leiomyomas.

  1999cited by this paper
• Multiple uterine leiomyomas: cytogenetic analysis.

  1999cited by this paper
• Telomere shortening in uterine leiomyomas.

  1998cited by this paper
• Desmoid tumor is a clonal cellular proliferation: PCR amplification of HUMARA for analysis of patterns of X-chromosome inactivation.

  1997cited by this paper
• Familial predisposition to uterine leiomyomas

  1995cited by this paper
• Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions.

  1995cited by this paper
• Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence.

  1995cited by this paper
• BLAUSTEIN'S PATHOLOGY OF THE FEMALE GENITAL TRACT

  1995cited by this paper
• Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene.

  1995cited by this paper
• Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata

  1994cited by this paper
• Clusters of chromosome 9 aberrations are associated with clinico‐pathologic subsets of non‐Hodgkin's lymphoma

  1993cited by this paper
• Independent origin of uterine leiomyomas with karyotypically identical alterations.

  1992cited by this paper
• Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation.

  1992cited by this paper
• [A classification of uterine tumors based on embryogenesis].

  1991cited by this paper
• Cytogenetic Abnormalities in Uterine Leiomyomata

  1991cited by this paper
• Uterine leiomyoma cytogenetics

  1990cited by this paper
• Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12;14), in 44 uterine leiomyomas

  1990cited by this paper
• Chromosomal patterns in human benign uterine leiomyomas.

  1990cited by this paper
• The frequency of uterine leiomyomas.

  1990cited by this paper
• Different karyotypic abnormalities, t(1;6) and del(7), in two uterine leiomyomas from the same patient.

  1989cited by this paper
• Mesenchymal Tumors of the Uterus

  1987cited by this paper
• Mammalian X-chromosome inactivation.

  1983cited by this paper
• Uterine leiomyomata: etiology, symptomatology, and management.

  1981cited by this paper
• Clonal origin of human tumors.

  1979cited by this paper
• Clonal origin of human tumors.

  1976cited by this paper
• Cutaneous leiomyomata with uterine leiomyomata.

  1973cited by this paper
• Use of genetic markers to study cellular origin and development of tumors in human females.

  1972cited by this paper
• X‐CHROMOSOME INACTIVATION AND DEVELOPMENTAL PATTERNS IN MAMMALS

  1972cited by this paper
• Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase.

  1970cited by this paper

• Uterine fibroids at single-cell resolution: unveiling cellular heterogeneity to improve understanding of pathogenesis and guide future therapies.

  2025cites this paper
• HMGA2 overexpression induces plasticity in myometrial cells and a transcriptomic profile more similar to that of uterine fibroids.

  2024cites this paper
• Clinical and molecular risk factors for repeat interventions due to symptomatic uterine leiomyomas.

  2024cites this paper
• Cysteine-rich intestinal protein 1 is a novel surface marker for human myometrial stem/progenitor cells

  2023cites this paper
• Cysteine-Rich Intestinal Protein 1 is a Novel Surface Marker for Myometrial Stem/Progenitor Cells

  2023cites this paper
• Clonal Proliferation Within Smooth Muscle Cells in Unstable Human Atherosclerotic Lesions

  2023cites this paper
• A View on Uterine Leiomyoma Genesis through the Prism of Genetic, Epigenetic and Cellular Heterogeneity

  2023cites this paper
• Molecular Genetic Basis and Prospects of Gene Therapy of Uterine Leiomyoma

  2021cites this paper
• Hormonal Pathology of the Uterus

  2020cites this paper
• Putative human myometrial and fibroid stem-like cells have mesenchymal stem cell and endometrial stromal cell properties.

  2020cites this paper
• Role of Hormones in Common Benign Uterine Lesions: Endometrial Polyps, Leiomyomas, and Adenomyosis.

  2020cites this paper
• The mitochondrial DNA 4977‐bp deletion and copy number alteration in Han Chinese samples with uterine fibroids

  2019cites this paper
• Intravenous leiomyomatosis: molecular analysis of 17 cases.

  2019cites this paper
• Reasons to Reconsider Risk Associated With Power Morcellation of Uterine Fibroids

  2019cites this paper
• Pathogenomics of Uterine Fibroids Development

  2019cites this paper
• Uterine stem cells: from basic research to advanced cell therapies

  2018cites this paper
• Stem Cells and Uterine Fibroids

  2018cites this paper
• MicroRNAs involved in the HMGA2 deregulation and its co-occurrence with MED12 mutation in uterine leiomyoma

  2018cites this paper
• Biomarkers of Uterine Fibroids

  2018cites this paper
• Chronic Inflammation May Enhance Leiomyoma Development by the Involvement of Progenitor Cells

  2018cites this paper
• Uterine Fibroids and Adenomyosis

  2018influential citation
• Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease

  2017cites this paper
• Pathobiology of myomatosis uteri: the underlying knowledge to support our clinical practice

  2017cites this paper
• Epidemiological and familial risk factors of uterine leiomyoma development

  2017cites this paper
• Frequency and Spectrum of MED12 Exon 2 Mutations in Multiple Versus Solitary Uterine Leiomyomas From Russian Patients

  2016cites this paper
• THE ROLE OF MED 12 IN TUMORIGENESIS

  2016cites this paper
• Identification of uterine leiomyoma-specific marker genes based on DNA methylation and their clinical application

  2016cites this paper
• Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa

  2016cites this paper
• Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids

  2016cites this paper
• Prevalence of cellular leiomyoma and partially cellular leiomyoma in postoperative samples - analysis of 384 cases.

  2016cites this paper
• MED12 exon 2 mutations in uterine leiomyoma’s in women patients of Tehran Province of Iran

  2016cites this paper
• Molecular classification of uterine leiomyomas by genome-wide methods

  2016cites this paper
• Med12 gain-of-function mutation causes leiomyomas and genomic instability.

  2015cites this paper
• MED12: A NOVEL PLAYER IN UTERINE LEIOMYOMAS

  2015cites this paper
• Arteriosclerosis, Thrombosis, and Vascular Biology.

  2015cites this paper
• Genetic alterations in uterine fibroids – a new direction for pharmacological intervention?

  2015cites this paper
• Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

  2015cites this paper
• Stro-1/CD44 as putative human myometrial and fibroid stem cell markers.

  2015cites this paper
• Clonally related uterine leiomyomas are common and display branched tumor evolution.

  2015cites this paper
• Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma.

  2014cites this paper
• Tissue-Specific Stem Cells in the Myometrium and Tumor-Initiating Cells in Leiomyoma1

  2014cites this paper
• Genomics of uterine leiomyomas: insights from high-throughput sequencing.

  2014cites this paper
• Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues.

  2014cites this paper
• MED12 mutation frequency in unselected sporadic uterine leiomyomas.

  2014cites this paper
• The CD24hi smooth muscle subpopulation is the predominant fraction in uterine fibroids.

  2014cites this paper
• CARACTERIZAÇÃO DE MUTAÇÕES NO GENE MED12, DOS miRNAS MAPEADOS EM 7q22 E DOS CANDIDATOS A REGULAÇÃO DO GENE HMGA2 EM LEIOMIOMAS UTERINOS

  2013cites this paper
• Występowanie leiomyoma cellulare w materiale pooperacyjnym - opis sytuacji klinicznych

  2013cites this paper
• MED12 mutations occurring in benign and malignant mammalian smooth muscle tumors

  2013cites this paper
• Leiomyoma cellulare in postoperative material: clinical cases

  2013cites this paper
• Whole Exome Sequencing in a Random Sample of North American Women with Leiomyomas Identifies MED12 Mutations in Majority of Uterine Leiomyomas

  2012cites this paper
• Role of Stem Cells in Human Uterine Leiomyoma Growth

  2012cites this paper
• MED12 mutations in uterine fibroids—their relationship to cytogenetic subgroups

  2012cites this paper
• MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors

  2012cites this paper
• Expression Profiling of Protein Tyrosine Kinases and Their Ligand Activators in Leiomyoma Uteri

  2010cites this paper
• [Changes of mRNAs encoding alternatively spliced variants of procollagen C-endopeptidase in leiomyomas uteri depending on the phase of menstrual cycle and in postmenopausal women].

  2009cites this paper
• Platelet-Derived Growth Factor C Is Upregulated in Human Uterine Fibroids and Regulates Uterine Smooth Muscle Cell Growth

  2009cites this paper
• Platelet-Derived Growth Factor C Is Upregulated in Human Uterine Fibroids and Regulates Uterine Smooth Muscle Cell Growth 1

  2009cites this paper
• Platelet-Derived Growth Factor C Is Upregulated in Human Uterine Fibroids and Regulates Uterine Smooth Muscle Cell Growth1

  2009cites this paper
• Polymorphisms of CYP17A1, CYP19, and androgen in Brazilian women with uterine leiomyomas

  2008cites this paper
• [Molecular characteristics of leiomyoma uteri based on selected compounds of the extracellular matrix].

  2008cites this paper
• X-chromosomal inactivation analysis of uterine leiomyomas reveals a common clonal origin of different tumor nodules in some multiple leiomyomas.

  2007cites this paper